Carboplatin

Common brands: Kyxata, Abraxane, Paclitaxel Paclitaxel, Paclitaxel, Paclitaxel Protein Bound Particles Albumin Bound

Top reporter: Accord Healthcare, Inc.

Platinum-based Drug [EPC]Microtubule Inhibitor [EPC]Programmed Death Receptor-1 Blocking Antibody [EPC]Topoisomerase Inhibitor [EPC]Corticosteroid [EPC]
122,602
Total Reports
66,132
Serious Reports
19,569
Death Reports
30
Reported Reactions
Death Report Ratio: High (15.96%)

Patient Demographics

Male
43,826
Female
63,234

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Carboplatin.

# Reaction Reports % of Total
1 OFF LABEL USE 8,325
6.3%
2 NEUTROPENIA 7,282
5.5%
3 ANAEMIA 7,061
5.4%
4 NAUSEA 6,935
5.3%
5 FEBRILE NEUTROPENIA 6,436
4.9%
6 DIARRHOEA 6,088
4.6%
7 DISEASE PROGRESSION 5,957
4.5%
8 MALIGNANT NEOPLASM PROGRESSION 5,902
4.5%
9 THROMBOCYTOPENIA 5,778
4.4%
10 DYSPNOEA 5,322
4.1%
11 VOMITING 5,077
3.9%
12 PYREXIA 4,745
3.6%
13 FATIGUE 4,634
3.5%
14 DRUG INEFFECTIVE 4,273
3.3%
15 DEATH 4,233
3.2%
16 ASTHENIA 3,816
2.9%
17 PANCYTOPENIA 3,552
2.7%
18 MYELOSUPPRESSION 3,512
2.7%
19 PNEUMONIA 3,274
2.5%
20 RASH 3,088
2.4%
21 DECREASED APPETITE 2,832
2.2%
22 NEUTROPHIL COUNT DECREASED 2,733
2.1%
23 SEPSIS 2,701
2.1%
24 PRODUCT USE IN UNAPPROVED INDICATION 2,622
2.0%
25 NEUROPATHY PERIPHERAL 2,604
2.0%
26 PLATELET COUNT DECREASED 2,604
2.0%
27 ALOPECIA 2,539
1.9%
28 ACUTE KIDNEY INJURY 2,518
1.9%
29 WHITE BLOOD CELL COUNT DECREASED 2,482
1.9%
30 DEHYDRATION 2,284
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.